
A hammerhead shark swims near Wolf Island at Galapagos Marine Reserve in August 2013.
17:55 JST, May 15, 2024
QUITO (Reuters) — A team of researchers has discovered a potential breeding ground for smooth hammerhead sharks off an island in Ecuador’s Galapagos archipelago, in what would be a “very rare” sighting, the national park said in a statement on May 2.
The so-called “nursery” would be the first breeding site for smooth hammerheads, or Sphyrna zygaena, in the Galapagos if confirmed, the park said.
The smooth hammerhead is one of nine known species of hammerhead shark. It is considered “vulnerable” on the International Union for Conservation of Nature’s list of threatened species.
Scientists on a Greenpeace expedition toured the Galapagos Marine Reserve several weeks ago, spotting a young female hammerhead off of Isabela Island, the Galapagos’ largest island, and tagging her.
Researchers will continue to monitor the shark to confirm that she was in a breeding area.
The Galapagos Islands with its unique wildlife was critical to British scientist Charles Darwin’s theory of evolution. It is home to many species not found elsewhere such as giant tortoises, flightless cormorants and marine iguanas.
Many are also in danger of extinction.
Top Articles in Science & Nature
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed
-
Record 700 Startups to Gather at SusHi Tech Tokyo in April; Event Will Center on Themes Like Artificial Intelligence and Robotics
-
Parents in Japan to Get Instagram Notifications When Teens Repeatedly Search for Suicide Content
-
iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel
-
Japan to Ban Use of Power Banks on Airplanes
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

